A Study of LM-168 Combined With Other Anti-tumor Treatments in Participants With Advanced Solid Tumors

Clinical trial NCT07669415 · RECRUITING

Trial details

NCT number: NCT07669415
Sponsor: LaNova Medicines Limited
Status: RECRUITING
Phase: Phase 2
Study type: INTERVENTIONAL

Advanced Solid Tumor

Start date: 2026-07-29
Primary completion: 2027-12-15
Enrollment: 108

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.